375 related articles for article (PubMed ID: 11385732)
1. The influence of genetic background on spontaneous and genetically engineered mouse models of complex diseases.
Linder CC
Lab Anim (NY); 2001 May; 30(5):34-9. PubMed ID: 11385732
[TBL] [Abstract][Full Text] [Related]
2. Mouse models of human genetic disease: which mouse is more like a man?
Erickson RP
Bioessays; 1996 Dec; 18(12):993-8. PubMed ID: 8976156
[TBL] [Abstract][Full Text] [Related]
3. Spontaneous and engineered mutant mice as models for experimental and comparative pathology: history, comparison, and developmental technology.
Roths JB; Foxworth WB; McArthur MJ; Montgomery CA; Kier AB
Lab Anim Sci; 1999 Feb; 49(1):12-34. PubMed ID: 10090091
[TBL] [Abstract][Full Text] [Related]
4. Mouse nomenclature and maintenance of genetically engineered mice.
Linder CC
Comp Med; 2003 Apr; 53(2):119-25. PubMed ID: 12784845
[TBL] [Abstract][Full Text] [Related]
5. Behavioural phenotyping of transgenic mice.
Brown RE
Can J Exp Psychol; 2007 Dec; 61(4):328-44. PubMed ID: 18266509
[TBL] [Abstract][Full Text] [Related]
6. [Genetically engineered mice and its application to bioindustry].
Koda T; Togashi Y; Nishimura T
Hokkaido Igaku Zasshi; 2002 Mar; 77(2):151-6. PubMed ID: 11968850
[TBL] [Abstract][Full Text] [Related]
7. Effect of the genetic background on the phenotype of mouse mutations.
Montagutelli X
J Am Soc Nephrol; 2000 Nov; 11 Suppl 16():S101-5. PubMed ID: 11065339
[TBL] [Abstract][Full Text] [Related]
8. Genetic engineering in the mouse: tuning TNF/TNFR expression.
Douni E; Alexiou M; Kollias G
Methods Mol Med; 2004; 98():137-70. PubMed ID: 15064438
[TBL] [Abstract][Full Text] [Related]
9. Reduced penetrance of craniofacial anomalies as a function of deletion size and genetic background in a chromosome engineered partial mouse model for Smith-Magenis syndrome.
Yan J; Keener VW; Bi W; Walz K; Bradley A; Justice MJ; Lupski JR
Hum Mol Genet; 2004 Nov; 13(21):2613-24. PubMed ID: 15459175
[TBL] [Abstract][Full Text] [Related]
10. [Application and recent advances of laboratory mouse in human cancer research].
Liu EQ; Kitajima S; Morimoto M
Ai Zheng; 2005 Feb; 24(2):249-54. PubMed ID: 15694046
[TBL] [Abstract][Full Text] [Related]
11. Practical development of genetically engineered animals as human disease models.
Nomura T
Lab Anim Sci; 1997 Apr; 47(2):113-7. PubMed ID: 9150486
[TBL] [Abstract][Full Text] [Related]
12. Animal models of psoriasis: a critical appraisal.
Schön MP
Exp Dermatol; 2008 Aug; 17(8):703-12. PubMed ID: 18557923
[TBL] [Abstract][Full Text] [Related]
13. Immunological variation between inbred laboratory mouse strains: points to consider in phenotyping genetically immunomodified mice.
Sellers RS; Clifford CB; Treuting PM; Brayton C
Vet Pathol; 2012 Jan; 49(1):32-43. PubMed ID: 22135019
[TBL] [Abstract][Full Text] [Related]
14. Probing p53 biological functions through the use of genetically engineered mouse models.
Attardi LD; Donehower LA
Mutat Res; 2005 Aug; 576(1-2):4-21. PubMed ID: 16038709
[TBL] [Abstract][Full Text] [Related]
15. [The mouse model and human disease].
Kung HF; Huang JD
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Feb; 23(1):2-7. PubMed ID: 12905807
[TBL] [Abstract][Full Text] [Related]
16. Effects of the genetic background on cognitive performances of TG2576 mice.
Lassalle JM; Halley H; Daumas S; Verret L; Francés B
Behav Brain Res; 2008 Aug; 191(1):104-10. PubMed ID: 18433892
[TBL] [Abstract][Full Text] [Related]
17. Identification of therapeutic drug targets through genetically manipulated mice: are we getting it right?
Matthaei KI
Pharmacol Ther; 2009 Jul; 123(1):32-6. PubMed ID: 19375454
[TBL] [Abstract][Full Text] [Related]
18. [Murine models for human diseases].
Benavides F; Guénet JL
Medicina (B Aires); 2001; 61(2):215-31. PubMed ID: 11374148
[TBL] [Abstract][Full Text] [Related]
19. Experimental use of murine lupus models.
Peng SL
Methods Mol Med; 2004; 102():227-72. PubMed ID: 15286389
[TBL] [Abstract][Full Text] [Related]
20. Genetically engineered animals in drug discovery and development: a maturing resource for toxicologic research.
Bolon B
Basic Clin Pharmacol Toxicol; 2004 Oct; 95(4):154-61. PubMed ID: 15504150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
